Press release
FICFF Names Max Alexander as Ambassador for the Stitching Dreams Program
From left to right: Abigail Posner, Lucie Brigham, Yitong Qin, Max Alexander, Maribel Lieberman, Andy Yu
New York - September 24, 2024 - The Fashion in a Conscious Future Foundation (FICFF) is proud to announce that Max Alexander, an 8-year-old fashion prodigy, has officially become the Ambassador of the Stitching Dreams Aesthetic Education Program.
Max was introduced during FICFF's special forum held at the SDG Media Zone during the 79th United Nations General Assembly in New York, focusing on the theme "Stitching Hope: Empowering Futures through Fashion, Sustainability, and Leadership." The forum featured a diverse panel of experts, including Abigail Posner - Director of US Creative Works at Google, Lucie Brigham - Chief of Office at the United Nations Office for Partnerships and Co-Founder of the United Nations Fashion and Lifestyle Network, Yitong Qin - Founder and CEO of UNIPX Group and Founder & Co-Chair FICFF, Maribel Lieberman - Founder and CEO of MARIEBELLE, and Andy Yu, Fashion Artist & Designer and Co-Chair of FICFF, who discussed how fashion can be a force for change-empowering underprivileged children, preserving cultural heritage, and fostering leadership in sustainability.
Max has been widely recognized for his creativity and commitment to sustainable fashion, making him the role model to inspire the next generation. During the forum, he shared his personal journey in fashion, especially his practice to incorporate sustainability in his works, and encouraged young designers to integrate sustainability into their work. He also presented four stunning designs using eco-friendly materials, demonstrating the possibilities of sustainable fashion to a captivated audience.
FICFF's Stitching Dreams program aims to empower children by providing educational resources and sustainable clothing, blending traditional culture and modern design. This program recently brought sustainable clothing to children in the remote areas of Southwest China, showcasing how fashion can be a vehicle for both cultural preservation and environmental awareness.
As FICFF's newest ambassador, Max will play a key role in spreading awareness of the Stitching Dreams program, advocating for sustainability, and inspiring children to pursue their dreams through fashion and creativity.
FICFF co-founder Yitong Qin said, "Max embodies the spirit of sustainable fashion and creativity. His passion aligns perfectly with our mission to create a more responsible and inclusive future through fashion. We are excited to have him on board as our ambassador."
About FICFF
The Fashion in a Conscious Future Foundation (FICFF) is a non-profit organization based in New York, dedicated to transform fashion into a catalyst for global change. By harnessing the universal power of fashion, FICFF champions the United Nations Sustainable Development Goals (SDGs), focusing on innovation, sustainability, and equity. The mission of FICFF is to shape a more sustainable, conscious, and just future through the influence of fashion.
Media Contact
Company Name: Fashion in a Conscious Future Foundation (FICFF)
Contact Person: Yulia Lin
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ficff-names-max-alexander-as-ambassador-for-the-stitching-dreams-program]
Country: United States
Website: https://ficff.org/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FICFF Names Max Alexander as Ambassador for the Stitching Dreams Program here
News-ID: 3666307 • Views: …
More Releases from ABNewswire
PI3K Inhibitors Market Outlook: Roche, Novartis, and Emerging Biotechs Drive Com …
DelveInsight's comprehensive analysis reveals robust growth potential in the PI3K inhibitors market across 7MM through 2034. Key players include Roche/Genentech (ITOVEBI), Novartis (PIQRAY), Gilead Sciences (ZYDELIG), Kazia Therapeutics (Paxalisib), Celcuity (Gedatolisib), and others, with expanding applications from hematological to solid tumor indications driving market momentum.
PI3K Inhibitor Key Takeaways
*
PI3K Inhibitor market size projection: As per DelveInsight's analysis, the total market size of PI3K inhibitors in the 7MM is expected to…
Bunion Market to Experience Growth by 2034, DelveInsight | Companies involved Sy …
Bunion Treatment Market Report provides real-world prescription pattern analysis, emerging drugs, market share of individual therapies, and historical and forecasted 7MM Bunion market size from 2020 to 2034. The report also covers current Bunion treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.
Emerging bunion therapies, including Magnezix CS and Lapiplasty 3-Dimensional Bunion Correction, are poised to boost market growth by providing innovative,…
PDE4 Inhibitors Market Growth Accelerates Amid FDA Approvals, Pipeline Expansion …
DelveInsight's PDE4 Inhibitor Market Report Reveals Significant Growth Through 2034, Led by Arcutis Biotherapeutics, Pfizer, Shionogi, Palisade Bio, UNION Therapeutics, Amgen, and Chiesi Farmaceutici with Key Assets Including ZORYVE, EUCRISA, OTEZLA, Zatolmilast, and PALI-2108 Across Multiple Inflammatory Conditions.
DelveInsight Business Research's extensive market analysis titled "Phosphodiesterase-4 (PDE4) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 [https://www.delveinsight.com/report-store/phosphodiesterase-4-pde4-inhibitor-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]," provides a comprehensive insights into this rapidly evolving therapeutic class across…
PD-L1 Inhibitors Market Dynamics: Robust Pipeline, Regulatory Wins, and Competit …
DelveInsight's PD-L1 Inhibitors Market Analysis reveals $36B market across 7MM, dominated by Merck's KEYTRUDA and BMS's OPDIVO. Key players include Genentech, AstraZeneca, Regeneron, Pfizer. Emerging pipeline features sasanlimab, HLX43, balstilimab. Patent expirations in 2028 expected to reshape competitive landscape with biosimilar entry anticipated.
PD-L1 Inhibitors Market Key Takeaways
*
Market size projection: As per DelveInsight's analysis, the total market size of PD-L1 inhibitors in the 7MM is expected to surge significantly from…
